Singapore: 3SBio, China based biotechnology company, has signed license agreement with JenKem Technology to develop, man...
Singapore: Japanese firm Takeda Pharmaceutical has formed a research collaboration with the BC Cancer Agency to explore ...
Singapore: With the strategy to strengthen its pain management portfolio, global biopharmaceutical company, Teva Pharmac...
Singapore: The Japanese government has plans to help private-sector companies in exporting as early as 2015 regenerative...
Bayer HealthCare received approval in Japan for Gadovist (gadobutrol) injection for use with magnetic resonance imaging ...
Singapore: Australia-based GI Dynamics has conducted a new meta-analysis that demonstrates EndoBarrier Therapy, an endos...
Singapore: Data from the once-daily chronic obstructive pulmonary disease (COPD) clinical trial programs were presented ...
Singapore: The Korea Drug Development Fund (KDDF) has chosen PAREXEL International, a leading global biopharmaceutical s...
Singapore: Non-small cell lung cancer (NSCLC) therapeutics market value in the Asia-Pacific (APAC) region, Australia, Ch...
Singapore: Glaxosmithkline declared that the phase III study of two anti-HER2 agents lapatinib and trastuzumab did not m...
Singapore: Focusing on the medical application of nanotechnology, Nanyang Technological University (NTU) in Singapore ...
Singapore: The National Institutes of Health (NIH), US, plans to invest an additional $100 million over the next three ...
Singapore: Almac said that Asian clinical trials must adopt highest GMP and GDP standards. Speaking to a news report, Mr...
Singapore: Global Pharmaceutical company, Merck, and Samsung Bioepis, a joint venture between Samsung Biologics and Biog...
Excelra, headquartered in Hyderabad, India, has announced its collaboration with H M Pharma Consultancy (HMPC), a life s...
Singapore: Boehringer Ingelheim Biopharmaceuticals has installed a fast track process transfer to commercial scale. Comp...
Singapore: US Food and Drug Administration (FDA) has approved Merck's RAGWITEK Tablet indicated as immunotherapy for the...
Singapore: Australian drug development company Agenix has appointed international biomedical business development expert...
